# A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

> **NCT05667506** · PHASE1,PHASE2 · RECRUITING · sponsor: **Juventas Cell Therapy Ltd.** · enrollment: 47 (estimated)

## Conditions studied

- B-cell Acute Lymphoblastic Leukemia

## Interventions

- **BIOLOGICAL:** single dose of CNCT19

## Key facts

- **NCT ID:** NCT05667506
- **Lead sponsor:** Juventas Cell Therapy Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-07
- **Primary completion:** 2025-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667506, "A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05667506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*